Please login to the form below
allergy
This page shows the latest allergy news and features for those working in and with pharma, biotech and healthcare.
J&J could launch its single-dose COVID-19 vaccine in March
of Allergy and Infectious Diseases (NIAID).
Latest news
-
EU authorises Aimmune’s peanut allergy treatment Palforzia
In Europe, 17 million people are affected by food allergies, with a peanut allergy being one of the most common. ... Aimmune’s potential rival, DBV Technologies, has not had as much success with getting its peanut allergy treatment approved.
-
J&J completes enrolment for late-stage COVID-19 vaccine trial
The phase 3 ENSEMBLE trial is being conducted in collaboration with the US Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID).
-
Canada joins UK in approving Pfizer/BioNTech COVID-19 vaccine
According to the BBC, Health Canada is advising that only those with an allergy to any of the ingredients used within BNT162b2 to not get the jab, adding that they will
-
FDA briefing document paves the way for Pfizer/BioNTech COVID-19 vaccine approval
Following the approval, the director of the US National Institute of Allergy and Infectious Diseases (NIAID) Dr Anthony Fauci initially commented that the UK’s approval process for the vaccine had
-
NIAID chief back-pedals on criticism of UK's Pfizer vaccine approval process
Anthony Fauci apologised for previous comments in BBC interview. The director of the US National Institute of Allergy and Infectious Diseases (NIAID) Dr Anthony Fauci (pictured above) has apologised after previously
More from news
Approximately 17 fully matching, plus 220 partially matching documents found.
Latest Intelligence
-
The pandemic preparedness paradox
In the United States, the National Institute of Allergy and Infectious Diseases alone spends $6bn annually in the labs of some of the best and brightest scientists in the world.
-
The search for effective drug treatments for COVID-19
medicine. to contribute to the medical response in public health emergencies. The EUA was based on then available data from two global clinical trials – the National Institute for Allergy and Infectious
-
Exploring the potential of eosinophils
when starting his research career in Southampton, UK before going on to be Professor of Allergy and Respiratory Medicine at Southampton University. ... Working as a clinician at this time meant he was caring for patients with allergies and asthma, in
-
As COVID-19 takes over the world, biopharma fights back
I don’t think the ongoing trials will tell us a lot,” said H Clifford Lane, clinical director at the National Institutes of Allergy and Infectious Diseases (NIAID).
-
Cortellis Drugs to Watch in 2020 report
This year’s list also highlights three first-in class medicines compared with last year’s list, which contained only one first-in-class medicine, peanut allergy vaccine Palforzia.
More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.
Latest appointments
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
Before AstraZeneca, she worked for GlaxoSmithKline for four years in a number of roles, including therapy specialist for its allergy portfolio.
-
ALK-Abello appoints Søren Jelert as CFO
He will be based at the company’s headquarters in Denmark. Dansih allergy immunotherapy company ALK-Abello has appointed Søren Jelert as its new chief financial officer, a role that sees ... to become a truly global allergy company.”.
-
Cytovation expands management team
Grego is currently chief executive officer of Spire Bioventures, a global healthcare consultancy and mentoring service, and has previously held a number of management positions at Spanish allergy specialist Laboratorios LETI.
-
Lars Dreiøe joins Sobi in senior quality and compliance role
He will join the firm in January from Danish allergy vaccine company ALK Abelló, where he was international head of quality.
-
ARC names chairman and member of the board
ARC is a privately held biopharma company developing desensitisation treatments for food allergies. ... Iwicki said: “ARC is working to address a very compelling therapeutic area and provide an option to those dealing with food allergies.
More from appointments
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
Lifesaving QR Code Wearable Launched to Help Emergency Services
Whilst a mi-SOS user can inform the public about underlying health conditions, a user can also update their profile with additional details such as allergies, critical care plans, COVID-19
-
Wilmington Healthcare appoints new consultants
for its allergy portfolio.
-
Blog: The Future of Food Allergy? The Emergence of Targeted Allergy Treatments
Research Analyst Rachel Arthurs explores how public exposure to the complications of food allergy has affected attitudes toward treatment. ... This is not an isolated incident, but a constant fear and source of anxiety for allergy sufferers all over the
-
Atopic Dermatitis — Going Beyond the Pill
The majority of patients start to experience symptoms before they reach 5 years of age and often suffer from asthma or other allergies.
-
Barber shops provide a short cut to BP reduction
Allergy testing in flower shops? Why not? All it requires is localised expertise, and a government that is keen to devolve the complexity and cost of healthcare, which the NHS is
More from PMHub
Approximately 3 fully matching, plus 12 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Nucleus Global announces a trio of promotions
- Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%
- Pfizer/BioNTech reach vaccine supply agreement with COVAX
- Trial combining British and Russian COVID-19 vaccines could begin in February
- New study identifies drugs that are safe to use in COVID-19 treatment
- AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU
- The UK has approved the first vaccine for COVID-19. What now?
- Clinical trials and the diversity principle
- Publicis Health UK Launches Unique Agency Offering for Clients Under Langland
- Sanofi will provide manufacturing support for Pfizer/BioNTech’s COVID-19 vaccine
- Unfinished Plans featured in Daily Mail as actor urges young people struggling with thoughts of suicide to speak out
- Onyx Health Launch National Competition for Life Science SMEs
PMHub
OPEN Health
OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...
Latest intelligence
- The UK has approved the first vaccine for COVID-19. What now?
- The authorisation of Pfizer/BioNtech's mRNA vaccine by the MHRA is great news, but no-one has ever tried to roll out a vaccine as rapidly as this one, so we have...
- Clinical trials and the diversity principle
- If they were ever really hidden, 2020 revealed the expensive-sounding problems limiting diversity in clinical trials. Solutions are overdue....
- Mapping at launch: it’s time to update the satnav
- How mapping familiar basics can provide a new GPS for market access strategy that drives brand success...
Quick links
Infographics
